Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.
- DOI
- 10.1186/s13058-021-01433-8
- Published
- 2021 May 21
- Container
- Breast cancer research : BCR
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13058-021-01433-8,
title = {Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.},
author = {Jacquemetton J and Kassem L and Poulard C and Dahmani A and De Plater L and Montaudon E and Sourd L and Morisset L and El Botty R and Chateau-Joubert S and Vacher S and Bièche I and Treilleux I and Trédan O and Marangoni E and Le Romancer M},
year = {2021},
journal = {Breast cancer research : BCR},
doi = {10.1186/s13058-021-01433-8},
url = {https://doi.org/10.1186/s13058-021-01433-8}
}RIS
TY - JOUR TI - Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant. AU - Jacquemetton J AU - Kassem L AU - Poulard C AU - Dahmani A AU - De Plater L AU - Montaudon E AU - Sourd L AU - Morisset L AU - El Botty R AU - Chateau-Joubert S AU - Vacher S AU - Bièche I AU - Treilleux I AU - Trédan O AU - Marangoni E AU - Le Romancer M PY - 2021 JO - Breast cancer research : BCR DO - 10.1186/s13058-021-01433-8 UR - https://doi.org/10.1186/s13058-021-01433-8 ER -
APA
J, J., L, K., C, P., A, D., L, D. P., E, M., L, S., L, M., R, E. B., S, C., S, V., I, B., I, T., O, T., E, M., & M, L. R. (2021). Analysis of genomic and non-genomic signaling of estrogen receptor in PDX models of breast cancer treated with a combination of the PI3K inhibitor alpelisib (BYL719) and fulvestrant.. Breast cancer research : BCR. https://doi.org/10.1186/s13058-021-01433-8
Source records
- pubmed · retrieved 2026-09-27T15:19:31.102Z